89 related articles for article (PubMed ID: 3358761)
1. Biologically active calcitonin analogs which have minimal interactions with phospholipids.
Epand RM; Epand RF; Orlowski RC
Biochem Biophys Res Commun; 1988 Apr; 152(1):203-7. PubMed ID: 3358761
[TBL] [Abstract][Full Text] [Related]
2. The biological potency of a series of analogues of human calcitonin correlates with their interactions with phospholipids.
Epand RF; Orlowski RC; Epand RM
Biopolymers; 2004; 76(3):258-65. PubMed ID: 15148685
[TBL] [Abstract][Full Text] [Related]
3. Amphipathic helix and its relationship to the interaction of calcitonin with phospholipids.
Epand RM; Epand RF; Orlowski RC; Schlueter RJ; Boni LT; Hui SW
Biochemistry; 1983 Oct; 22(22):5074-84. PubMed ID: 6652057
[TBL] [Abstract][Full Text] [Related]
4. Deletion sequences of salmon calcitonin that retain the essential biological and conformational features of the intact molecule.
Epand RM; Epand RF; Stafford AR; Orlowski RC
J Med Chem; 1988 Aug; 31(8):1595-8. PubMed ID: 3397998
[TBL] [Abstract][Full Text] [Related]
5. Presence of an amphipathic helical segment and its relationship to biological potency of calcitonin analogs.
Epand RM; Epand RF; Orlowski RC
Int J Pept Protein Res; 1985 Jan; 25(1):105-11. PubMed ID: 3880517
[TBL] [Abstract][Full Text] [Related]
6. Effects of lipid structure on peptide-lipid interactions. Complexes of salmon calcitonin with phosphatidylglycerol and with phosphatidic acid.
Hui SW; Epand RM; Dell KR; Epand RF; Orlowski RC
Biochim Biophys Acta; 1984 May; 772(3):264-72. PubMed ID: 6722149
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the interaction of glucagon, human parathyroid hormone-(1-34)-peptide and calcitonin with dimyristoylphosphatidylglycerol and with dimyristoylphosphatidylcholine.
Epand RM; Epand RF; Orlowski RC; Flanigan E; Stahl GL
Biophys Chem; 1985 Nov; 23(1-2):39-48. PubMed ID: 4092081
[TBL] [Abstract][Full Text] [Related]
8. The hydrophobic moment of the amphipathic helix of salmon calcitonin and biological potency.
Epand RM; Seyler JK; Orlowski RC
Eur J Biochem; 1986 Aug; 159(1):125-7. PubMed ID: 3743567
[TBL] [Abstract][Full Text] [Related]
9. Conformational and biological properties of partial sequences of salmon calcitonin.
Epand RM; Stahl GL; Orlowski RC
Int J Pept Protein Res; 1986 May; 27(5):501-7. PubMed ID: 3733320
[TBL] [Abstract][Full Text] [Related]
10. Study of a series of analogs of salmon calcitonin in which alanine replaces leucine.
Epand RM; Epand RF; Orlowski RC
Eur J Biochem; 1990 Mar; 188(3):633-5. PubMed ID: 2331988
[TBL] [Abstract][Full Text] [Related]
11. Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane-loop regions.
Stroop SD; Nakamuta H; Kuestner RE; Moore EE; Epand RM
Endocrinology; 1996 Nov; 137(11):4752-6. PubMed ID: 8895343
[TBL] [Abstract][Full Text] [Related]
12. Evidence for calcitonin receptor heterogeneity: binding studies with nonhelical analogs.
Nakamuta H; Orlowski RC; Epand RM
Endocrinology; 1990 Jul; 127(1):163-9. PubMed ID: 2163309
[TBL] [Abstract][Full Text] [Related]
13. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
[TBL] [Abstract][Full Text] [Related]
14. Conformational flexibility and biological activity of salmon calcitonin.
Epand RM; Epand RF; Orlowski RC; Seyler JK; Colescott RL
Biochemistry; 1986 Apr; 25(8):1964-8. PubMed ID: 3707923
[TBL] [Abstract][Full Text] [Related]
15. Biologically potent analogues of salmon calcitonin which do not contain an N-terminal disulfide-bridged ring structure.
Orlowski RC; Epand RM; Stafford AR
Eur J Biochem; 1987 Jan; 162(2):399-402. PubMed ID: 3803393
[TBL] [Abstract][Full Text] [Related]
16. Analogue separates biological effects of salmon calcitonin on brain and renal cortical membranes.
Twery MJ; Seitz PK; Nickols GA; Cooper CW; Gallagher JP; Orlowski RC
Eur J Pharmacol; 1988 Oct; 155(3):285-92. PubMed ID: 3266153
[TBL] [Abstract][Full Text] [Related]
17. The helical propensity of KLA amphipathic peptides enhances their binding to gel-state lipid membranes.
Arouri A; Dathe M; Blume A
Biophys Chem; 2013; 180-181():10-21. PubMed ID: 23792704
[TBL] [Abstract][Full Text] [Related]
18. Interaction of atriopeptin III with lipids and detergents.
Epand RM; Stahl GL
Int J Pept Protein Res; 1987 Feb; 29(2):238-43. PubMed ID: 2952615
[TBL] [Abstract][Full Text] [Related]
19. Phospholipid structure determines the effects of peptides on membranes. Differential scanning calorimetry studies with pentagastrin-related peptides.
Surewicz WK; Epand RM
Biochim Biophys Acta; 1986 Apr; 856(2):290-300. PubMed ID: 3955044
[TBL] [Abstract][Full Text] [Related]
20. A noncyclical analog of salmon calcitonin (N alpha-propionyl Di-Ala1,7,des-Leu19 sCT) retains full potency without inducing anorexia in rats.
Yates AJ; Gutierrez GE; Garrett IR; Mencel JJ; Nuss GW; Schreiber AB; Mundy GR
Endocrinology; 1990 Jun; 126(6):2845-9. PubMed ID: 2351097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
